Brief: Mineralys Therapeutics Q2 EPS USD -0.66
12/08/2025 21:05
Aug 12 (Reuters) - Mineralys Therapeutics Q2 net income USD -43.274 million. Q2 operating income USD -46.746 million Q2 operating expenses USD 46.746 million
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway